Compounds > 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
Page last updated: 2024-08-26

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Cancer of Skin

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bihari, O; Eckhardt, S; Erdélyi, V; Fodor, J; Pollák, Z1

Other Studies

1 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Cancer of Skin

ArticleYear
Basal cell carcinoma treated with MTDQ and irradiation.
    Acta radiologica: oncology, radiation, physics, biology, 1979, Volume: 18, Issue:2

    Topics: Adult; Carcinoma, Basal Cell; Humans; Malondialdehyde; Premedication; Quinolines; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin; Skin Neoplasms; Tablets

1979